Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026
PR Newswire•29/10/2026•06:00 ET
1
Key Highlights
- ➤Q3 2026 results scheduled for release after market close November 5, 2026
- ➤Conference call set for 2:00 p.m. Pacific Time on November 5
- ➤Amphastar sells generic and proprietary injectable, inhalation, and intranasal products
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026 PR Newswire
RANCHO CUCAMONGA, Calif., October 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its third quarter of 2026 ended September 30, 2026, after the market closes on Thursday, November 5, 2026, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.
Get started
Create a free account to read the full story.